Here are three stocks with buy rank and strong value characteristics for investors to consider today, February 11th:
OMV Aktiengesellschaft OMVKY: This energy and chemicals company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.5% over the last 60 days.
OMV has a price-to-earnings ratio (P/E) of 5.96, compared with 7.30 for the industry. The company possesses a Value Score of A.
Pacira BioSciences, Inc. PCRX: This non-opioid pain management and regenerative health solutions company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 21% over the last 60 days.
Pacira has a price-to-earnings ratio (P/E) of 7.69, compared with 24.45 for the S&P 500. The company possesses a Value Score of A.
EZCORP, Inc. EZPW: This pawn services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
Ezcorp has a price-to-earnings ratio (P/E) of 10.33, compared with 15.30 for the industry. The company possesses a Value Score of A.
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Only $1 to See All Zacks' Buys and Sells
We're not kidding.
Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.
Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
EZCORP, Inc. EZPW: Free Stock Analysis Report
Pacira BioSciences, Inc. PCRX: Free Stock Analysis Report
OMV AG (OMVKY): Free Stock Analysis Report
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.